# Science Group plc (SAG.L) fundamentals

Data as of 2026-09-08. LSE, United Kingdom. Sector: Industrials / Professional Services. Price 575p, market value 232 millionp.

## Valuation
- **P/E (trailing): 16.9×** (5-yr avg 1905.9×, 3-yr avg 1915.5×). Science Group plc trades at 16.9× trailing earnings, well below its own five-year average of 1905.9×: cheap by its own standards. The Industrials median in the September 2026 study was 25.7×. Forward P/E is 12.2×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.07**. A PEG of 0.07 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 1.0×**. Each dollar of revenue is priced at 1.0×.
- **Price / book: 2.5×**. The shares trade at 2.5× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 4.0×**. Enterprise value is 4.0× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 18.6%** (5-yr avg 0.1%). Free cash flow equals 18.6% of the market value, above its five-year average of 0.1%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 5.9%**. The inverse of the P/E: 5.9% of the price is earned each year.

## Profitability
- **Gross margin: 41.0%**. Science Group plc keeps 41.0% of revenue after the direct cost of what it sells.
- **Operating margin: 25.1%**. 25.1% of revenue is left after running the business, an exceptional level.
- **Net margin: 29.8%**. 29.8% of each dollar of sales reaches the bottom line.
- **Return on equity: 32.2%**. 32.2% on shareholders' equity is excellent if it is not driven by leverage; sustained above 20% usually signals a competitive advantage.
- **Return on invested capital: 105.6%**. Return on all capital, debt included, is 105.6%: comfortably above what that capital costs.
- **Return on assets: 27.7%**. Each dollar of assets produces 27.7% of profit.

## Growth
- **Revenue growth (1 yr): 0.9%** (3-yr 9.0%/yr, 5-yr 8.7%/yr). Revenue grew 0.9% over the last year, against 8.7% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 184.6%** (3-yr 47.6%/yr, 5-yr 34.2%/yr). Earnings per share rose 184.6%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): 17.4%/yr**. Free cash flow has compounded at 17.4% a year over three years, lagging earnings: check whether profits are turning into cash.

## Financial health
- **Debt to equity: 0.14**. Debt is 0.14 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. Science Group plc holds more cash than debt.
- **Interest coverage: 22.9×**. Operating profit covers interest 22.9× over, a safe margin.
- **Current ratio: 2.38** (quick 2.36). Current assets cover the next year's liabilities 2.38 times.
- **Altman Z-score: 4.67**. A Z-score of 4.67 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 7/9**. 7 of 9 fundamental checks pass: strong and improving financials.

## Dividends
- **Dividend yield: 1.73%** (0p per share, trailing). Science Group plc yields 1.73%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 11%** (17% of free cash flow). 11% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 5**. 5 straight years of increases.
- **Dividend growth (5 yr): 32.0%/yr** (1-yr 0.0%). The dividend has compounded at 32.0% a year over five years, doubling roughly every 2 years at that pace.
- **Shareholder yield: 8.5%**. Dividends plus net buybacks return 8.5% of the market value a year.

## Price and momentum
- **Total return (1 yr): 3.1%** (YTD 5.4%, 3-mo -1.4%). The shares are up 3.1% over twelve months including dividends.
- **From 52-week high: -6.1%** (10.5% above the low). Trading 6% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 38**. An RSI of 38 is neutral.
- **Beta (1 yr): 0.16** (volatility 21%). Beta of 0.16 against the FTSE All-Share: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=SAG.L · Page: https://foliofundamentals.com/stocks/sag.l

Not investment advice.